The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma.

[1]  D. Waller,et al.  Is there a role for pre-operative contrast-enhanced magnetic resonance imaging for radical surgery in malignant pleural mesothelioma? , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[2]  S. Larson,et al.  Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. , 2003, The Journal of thoracic and cardiovascular surgery.

[3]  M. Alifano,et al.  Video-assisted mediastinoscopy: experience from 240 consecutive cases. , 2003, The Annals of thoracic surgery.

[4]  E. Rutgers,et al.  The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma. , 2003, The Annals of thoracic surgery.

[5]  Arnulf H Hölscher,et al.  Lymph node size and metastatic infiltration in non-small cell lung cancer. , 2003, Chest.

[6]  E. Ruffini,et al.  Trimodality management of malignant pleural mesothelioma. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  K R Abrams,et al.  Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems , 2000, Thorax.

[8]  V. Rusch,et al.  Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. , 1999, The Annals of thoracic surgery.

[9]  A. Alavi,et al.  Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. , 1998, Chest.

[10]  V. Rusch,et al.  The importance of surgical staging in the treatment of malignant pleural mesothelioma. , 1996, The Journal of thoracic and cardiovascular surgery.

[11]  J. Peto,et al.  Continuing increase in mesothelioma mortality in Britain , 1995, The Lancet.

[12]  J. Best,et al.  A comparison of cobalt (57Co) bleomycin scanning and contrast-enhanced CT scanning for assessment of the mediastinum in lung cancer. , 1990, Chest.

[13]  V. Rusch,et al.  The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma. , 1988, The Journal of thoracic and cardiovascular surgery.

[14]  T. Naruke,et al.  Lymph node mapping and curability at various levels of metastasis in resected lung cancer. , 1978, The Journal of thoracic and cardiovascular surgery.

[15]  M. Muers,et al.  Guidelines on the selection of patients with lung cancer for surgery , 2005 .

[16]  W. Richards,et al.  Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. , 1999, The Journal of thoracic and cardiovascular surgery.